Characterizing Safety and Clinical Outcomes Associated with High-Dose Micafungin Utilization in Patients with Proven Invasive Candidiasis

Characterizing Safety and Clinical Outcomes Associated with High-Dose Micafungin Utilization in Patients with Proven Invasive Candidiasis

Micafungin is the empiric antifungal agent of choice for the treatment of invasive candidiasis (IC). Pathophysiologic changes that occur in obese and/or critically ill patients can alter micafungin serum concentrations and the probability of target attainment. Although high doses of micafungin have...

Full description

Bibliographic Details
Main Authors: Victoria C. Grant, Kenneth Nguyen, Sasha Rodriguez, Anna Y. Zhou, Jacinda C. Abdul-Mutakabbir, Karen K. Tan
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Tropical Medicine and Infectious Disease
Subjects:
micafungin
invasive candidiasis
obesity
critically ill
Online Access:https://www.mdpi.com/2414-6366/7/2/23

Internet

https://www.mdpi.com/2414-6366/7/2/23

Similar Items